These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19703301

  • 1. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
    Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM.
    Breast Cancer Res; 2009; 11(4):R61. PubMed ID: 19703301
    [Abstract] [Full Text] [Related]

  • 2. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
    McHenry PR, Sears JC, Herrick MP, Chang P, Heckman-Stoddard BM, Rybarczyk M, Chodosh LA, Gunther EJ, Hilsenbeck SG, Rosen JM, Vargo-Gogola T.
    Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
    [Abstract] [Full Text] [Related]

  • 3. P190A RhoGAP is required for mammary gland development.
    Heckman-Stoddard BM, Vargo-Gogola T, Herrick MP, Visbal AP, Lewis MT, Settleman J, Rosen JM.
    Dev Biol; 2011 Dec 01; 360(1):1-10. PubMed ID: 21945077
    [Abstract] [Full Text] [Related]

  • 4. Angiogenic acceleration of Neu induced mammary tumor progression and metastasis.
    Oshima RG, Lesperance J, Munoz V, Hebbard L, Ranscht B, Sharan N, Muller WJ, Hauser CA, Cardiff RD.
    Cancer Res; 2004 Jan 01; 64(1):169-79. PubMed ID: 14729621
    [Abstract] [Full Text] [Related]

  • 5. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.
    J Clin Invest; 2008 Jan 01; 118(1):64-78. PubMed ID: 18079969
    [Abstract] [Full Text] [Related]

  • 6. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K, You WK, Kadoya K, Helgadottir H, Young LJ, Ellies LG, Chang Y, Cardiff RD, Stallcup WB.
    Breast Cancer Res; 2012 Apr 24; 14(2):R67. PubMed ID: 22531600
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM, Welsh J.
    Carcinogenesis; 2004 Dec 24; 25(12):2361-72. PubMed ID: 15333467
    [Abstract] [Full Text] [Related]

  • 9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA.
    Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P.
    Gene Ther; 1998 Mar 01; 5(3):388-93. PubMed ID: 9614559
    [Abstract] [Full Text] [Related]

  • 12. P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation.
    Gillette M, Bray K, Blumenthaler A, Vargo-Gogola T.
    PLoS One; 2013 Mar 01; 8(5):e65105. PubMed ID: 23717689
    [Abstract] [Full Text] [Related]

  • 13. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
    Campbell MJ, Wollish WS, Lobo M, Esserman LJ.
    In Vitro Cell Dev Biol Anim; 2002 Jun 01; 38(6):326-33. PubMed ID: 12513120
    [Abstract] [Full Text] [Related]

  • 14. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG, Oemler W, Naber SP, Tsichlis PN.
    Cancer Res; 2007 Jan 01; 67(1):167-77. PubMed ID: 17210696
    [Abstract] [Full Text] [Related]

  • 15. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA.
    Oncogene; 2006 Jun 01; 25(23):3325-34. PubMed ID: 16434967
    [Abstract] [Full Text] [Related]

  • 16. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.
    Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, Amano J, Kawakubo M, Kannagi R, Kimata K, Taniguchi S, Itano N.
    Am J Pathol; 2007 Mar 01; 170(3):1086-99. PubMed ID: 17322391
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
    Patel Y, Soni M, Awgulewitsch A, Kern MJ, Liu S, Shah N, Singh UP, Chen H.
    Oncogene; 2019 Jan 01; 38(3):445-453. PubMed ID: 30104710
    [Abstract] [Full Text] [Related]

  • 18. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K, Rygiel T, van der Valk M, Collard JG.
    J Cancer Res Clin Oncol; 2009 Jan 01; 135(1):69-80. PubMed ID: 18592271
    [Abstract] [Full Text] [Related]

  • 19. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
    Niemeyer CC, Spencer-Dene B, Wu JX, Adamson ED.
    Int J Cancer; 1999 May 17; 81(4):588-91. PubMed ID: 10225449
    [Abstract] [Full Text] [Related]

  • 20. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
    Howe LR, Chang SH, Tolle KC, Dillon R, Young LJ, Cardiff RD, Newman RA, Yang P, Thaler HT, Muller WJ, Hudis C, Brown AM, Hla T, Subbaramaiah K, Dannenberg AJ.
    Cancer Res; 2005 Nov 01; 65(21):10113-9. PubMed ID: 16267038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.